The Board is made up of people with personal experience of diabetes, healthcare experts and experienced business executives who are passionate about supporting people living with the condition and raising awareness of its impact on individuals and our community.
BCom LLB, LLM, FTIA, GAICD, Public Notary
Arthur Koumoukelis was appointed Chair of Diabetes NSW & ACT in November 2020, having joined as a board member in June of that year. Arthur was also appointed to the Board of Directors of Diabetes Australia in April 2020.
He holds a Bachelor of Commerce, Bachelor of Laws and Master of Laws. He is a Fellow of the Taxation Institute of Australia and a Graduate Member of the Australian Institute of Company Directors.
Arthur is a public notary and partner of Thomson Geer since 2018 and was formerly a partner of Gadens Lawyers Australia in Sydney, focusing on health and aged care as well as on not-for-profit organisations. As an adviser to the aged care and retirement village industries, he has a deep understanding of administrative law and the process of government.
He has conducted hearings on a wide range of commercial disputes in all major superior courts, including the High Court of Australia, and has conducted a leading case on Part IVA of the Income Tax Assessment Act 1997 (Cth).
BSc, Comm, Cert. Small Bus Man., Grad Dip Comp Sc (Psych) GAICD
Anna was appointed to the Board of Diabetes NSW & ACT in November 2012.
She holds graduate degrees in Science (Psychology), Information Technology (Systems Analysis) and a Master’s Degree in Commerce. Ms Pino is also a Graduate of the Australian Institute of Company Directors and a Harvard Alumnus.
Anna is CEO of Lighthouse Business Innovation Centre in Canberra, a unique and well respected business accelerator providing financial support, educational services, business advice and investment assistance to start-ups through to mature and established companies across Australia.
Anna also serves on a number of other not-for-profit and start up boards. Anna’s interest in diabetes stems from personal experience and a desire to improve both the understanding of the disease and the lives of those affected by it.
Geraldine Daley AM
Geraldine is a practicing solicitor admitted to both the Supreme Court of New South Wales and the High Court of Australia. She holds a Master in Laws and is an Accredited Specialist in her field. She is a graduate of the Australian Institute of Company Directors.
As an insatiable learner who relishes the opportunity to enrich her corporate knowledge base, she has undertaken further training in the areas of corporate governance, directors’ duties, bullying and harassment prevention, and employment and industrial law.
Geraldine is a Director of Colin Daley Quinn Solicitors, an incorporated legal practice. She specialises in litigation and dispute resolution, and is jointly responsible for the operational and executive management of the legal practice.
Geraldine utilises her extensive experience as a Claims Assessor to manage disputes brought to the Claims Assessment and Resolution Service of the Motor Accidents Authority. Geraldine has past experience serving as a Director on the boards of the Law and Justice Foundation of NSW (six years), the Law Society of NSW (nine years) and various other corporate entities. She currently holds memberships of the Australian Institute of Company Directors and of a variety of legal committees.
Her interest in the diabetes space stems from her own experiences. She believes that her personal interest, coupled with her skills and knowledge, enable her to meaningfully contribute to Diabetes NSW & ACT.
Professor Bruce King
MBBS PhD, FRACP, Paediatric Endocrinologist
Professor Bruce King is a Senior Paediatric Endocrinologist at John Hunter Children’s Hospital, Newcastle.
Bruce is the leader of a diabetes team that received the NSW Health Research and Innovation Award. The award was for translation of research to improve diabetes management while maintaining quality of life and minimising the impact of diabetes on families. Bruce also provides paediatric diabetes services to regional NSW including Tamworth, Ballina, Lismore and Grafton.
Bruce has held a number of prestigious positions including the secretary of the APEG diabetes subcommittee, member of the Australian Type 1 Diabetes Clinical Research Network, Chair of the Australian Growth Hormone Advisory Committee, member of the ISPAD advisory council, and a member of Diabetes NSW Children’s Services Committee.
Bruce’s research has been published in journals including Diabetes Care, Diabetologia, Diabetes, Diabetes Medicine, BMJ online and Paediatric Diabetes.
Bruce’s research currently involves the development of mathematical models to improve outcomes for people using insulin including injections, insulin pumps and the closed loop insulin pumps. He believes that the development of this technology will significantly improve the lives of people living with diabetes. Bruce’s research also includes dietary effects on glucose levels, weight gain, exercise, diabetes in very young children and coeliac disease. All Bruce’s research is focused on improving diabetes management for people living with diabetes.
Dr Michael Stanford AM
CitWA, MBA, MB BS, FAICD
Michael commenced as Independent President and Board Chair of Diabetes Australia on 6 April 2020. He has had a distinguished career in healthcare leadership and management with 23 years’ experience as a Chief Executive Officer and Managing Director of healthcare organisations, and Non-Executive Director experience across health services, aged care, higher education, the arts, and industry bodies.
He has had long involvement with research, and nine years on the Council of Curtin University including overseeing its establishment of a Medical school.
Michael is a non-executive director with Virtus Health, a leading Assisted Reproductive Services provider; and Nucleus Network – Australia’s leading Phase One Clinical Trial Centre. He is a Member of the Order of Australia for significant service to the health care sector and tertiary education.
Justine Cain joined Diabetes Australia as Group Chief Executive Officer in November 2021 and at that time was appointed to the Board of Directors of Diabetes NSW &ACT. Justine has held Executive and Board appointments with listed, privately owned and profit-for-purpose organisations, including more than a decade with private health insurer Medibank.
Justine brings to Diabetes Australia and Diabetes NSW & ACT an extensive knowledge of the health and human services sectors. This is complemented by her track record in leading and growing large-scale organisations to deliver a range of health services.
The experiences of friends, family members and colleagues living with diabetes has given Justine personal knowledge of the impact diabetes can have and the challenges of managing the condition day-to-day.
She is committed to creating a stronger, more unified voice for people with diabetes, generating more support for services and securing a greater investment in Type 2 diabetes prevention.
Justine holds a Bachelor of Laws and a Bachelor of Science (Psychology) from the Australian National University.